Poppelaars observed that the addition of C1-inhibitor to an ex vivo HD model significantly reduced the complement activation and the induction of pro-inflammatory cytokines, such as TNF-α, IL-6, and von Willebrand factor [20]. This evidence concerns the gene TNF and Huntington disease.